AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06775756 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: IMRT with reduced-dose and reduced-volume cervical prophylactic irradiation
Description: For N0 disease, only cover bilateral RPN and level II. For N1 disease, cover ipsilateral involved level plus subsequent level downword, and cover contralateral level RPN and level II. For N2 disease, cover ipsilateral involved level plus subsequent level downword. For N3 disease, cover ipsilateral involved level plus subsequent level downword, and ensuring a 2cm margin below GTVn if GTVn reach or near the sternoclavicular joint. Notably, for unilateral N3, the contralateral neck would only include RPN and level II. Prescribing dose for CTVn2 was 50Gy/33Fx.
Study NCT05973071 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tuune Supplemented Contraceptive Visit
Description: Participants complete the Tuune contraceptive decision aid health questionnaire (Tuune for clinics) as part of their standard OBGYN clinic appointment.
Study NCT05973071 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Contraceptive Visit
Description: Participants will complete a standard OBGYN clinic appointment without using the Tuune contraceptive decision aid health questionnaire (Tuune for Clinics).
Study NCT06549595 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0486
Description: a fully human bispecific monoclonal IgG4 antibody
Study NCT06549595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R-CHOP
Description: Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
Study NCT05493111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AR-15512 Ophthalmic Solution
Description: Topical ocular administration of one drop in both eyes BID for 365 days.
Study NCT05493111 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Topical ocular administration of one drop in both eyes BID for 365 days.
Study NCT06107088 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Active 1
Description: lactase enzyme
Study NCT06107088 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active 1
Description: lactase enzyme
Study NCT06107088 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active 2
Description: lactase-bacterial strain combination
Study NCT06107088 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Active 3
Description: bacterial strain alone
Study NCT06107088 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT06107088 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT06107088 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: placebo
Study NCT05208411 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Project ImPACT: Improving Parents As Communication Teachers
Description: Project ImPACT (Improving Parents As Communication Teachers, Ingersoll \& Dvortcsak, 2019) is a promising evidence-based parent-mediated intervention that is part of a class of naturalistic, developmental, behavioral interventions (NBDIs). NBDIs involve the use of behavioral principles of learning to teach skills chosen from a developmental sequence in naturalistic play-setting and using natural rewards. Skills selected as relevant for intervention are those that allow the child to participate more fully within reciprocal interactions with the adult. In recent years the program has been adapted for use with infants and toddlers at elevated likelihood of ASD. These adaptations have made this program appropriate for younger children and children who are experiencing social communication delays but do not have an ASD diagnosis.
Study NCT06564675 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: C-Trend Index
Description: C-trend-Index is collected blinded from the patients using Brainstatus device. The device shows and collects also cEEG. These are analyzed retrospectively after all study patients have their 6-month follow-up data collected. The intervention does not affect clinical management or decision-making.
Study NCT06549595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R-CVP
Description: Rituximab, Cyclophosphamide, Vincristine and Prednisone
Study NCT06549595 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BR
Description: Bendamustine, Rituximab
Study NCT04942171 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation catheter ablation group
Description: 1. Pulmonary vein isolation~2. Additional treatment for lesions caused by non-pulmonary veins~3. Esophageal temperature monitoring to prevent damage to the esophagus~4. Evaluation of procedure time and radiofrequency ablation time~5. Evaluation of complications after the procedure~6. Rhythm follow-up after the procedure is conducted in accordance with the above study design.~7. Conduct a survey on cognitive function and emotion before and 12 months after the procedure
Study NCT04942171 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Medical therapy group
Description: 1. Use of beta-blockers or calcium channel blockers for pulse rate control~2. Antiarrhythmic drugs are administered to patients with highly symptomatic atrial fibrillation symptoms even after pulse rate control.~3. If symptoms are not controlled even with antiarrhythmic drugs, electrical conversion to restore sinus rhythm.~4. To prevent cerebral infarction, maintain optimal anticoagulant therapy according to the risk score for cerebral infarction.~5. Conduct a questionnaire on cognitive function and emotion before and 12 months after the procedure
Study NCT05613660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Veg Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water
Study NCT05613660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bovine Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water
Study NCT05613660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish | Marine Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water
Study NCT05613660 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Chicken Collagen Peptide
Description: Mode of Usage: 1 scoop/sachet daily Route of Administration: Oral administration with a glassful (approx. 250 mL) of water
Study NCT05576935 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stroop task
Description: The task is partitioned in 4 blocks of 360 stimuli and each word will be presented on screen in 34 point font for 1000 ms with an inter-stimulus interval based on their performance on the Stroop max test. This max test will be performed during the familiarization trial, and is divided in blocks of 96 stimuli. After each block, the accuracy (ACC) will be calculated. When ACC > 85%, the difficulty of the Stroop task will be increased by decreasing the stimulus presentation time (SPT). If ACC \< 85%, this block will be considered as an 'error' and the subject must redo the block without changing the SPT. The first block will have a SPT of 1500 ms. When the required ACC is achieved, the SPT will decrease in the following order: 1100, 900, 800,... to determine the individualized cognitive load. When the subject makes 3 errors in a row, or 5 errors during the whole trial, the trial will end. The SPT of the last block will be considered as the maximum capacity of that individual.
Study NCT05576935 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Documentary
Description: In order to avoid under- and over-arousal, participants will have the opportunity to choose between several documentaries. The participants will also receive a list of the available documentaries (based on selections from Netflix and Disney+) after the familiarization trial so that the trial can go as smoothly as possible.
Study NCT04729829 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social and behaviour change communication
Description: Each SBC treatment community will receive nutrition content and learning through savings groups. The group members will participate in skill-building activities that promote five key behaviours about fish nutrition and household decision making on fish consumption as part of facilitated discussions, interactive learning sessions, and a video-based facilitated dialogue. Increased fish consumption through SBC mass attendance events through marketing of fish vendors, interactive learning, and edu-tainment competitions promoting fish consumption. SBC will raise awareness of the benefits of eating fish as part of a balanced diet, with a particular focus on pregnant and lactating mothers, and children under 5 years of age.
Study NCT06204731 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and environmental conditions
Description: Participants will engage in interval training and will reside and sleep at different altitudes for a period of 4 weeks. Aerobic and anaerobic capacity tests and an eccentric exercise test will be performed before and after the training intervention. Before and after the training program, somatic measurements will also be taken. Before and after the first and last workout, blood will be drawn for biochemical analysis.
Study NCT04729829 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fish aggregating device
Description: This is a moored line attached to buoys in coastal waters that attracts oceanic fish to it, to make it easier for small-scale fishers to catch them using their existing gear and boats. This FAD will work to increase the catch rate and hence, the availability of fish for sale in upland community markets.
Study NCT05294068 — intervention group
Intervention type: OTHER
Intervention: standard of care for patients with cognitive impairments
Description: clinical examination, radiological, biological and physiological examinations.
Study NCT05294068 — intervention group
Intervention type: OTHER
Intervention: standard of care for patients with neuromotor impairments
Description: clinical examination, radiological, biological and physiological examinations.
Study NCT05294068 — intervention group
Intervention type: OTHER
Intervention: standard of care for patients with sensory impairments
Description: clinical examination, radiological, biological and physiological examinations.
Study NCT05547139 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Protocolized weaning of respiratory support
Description: The protocolized weaning aims to keep babies on CPAP for a longer period of time and will measure how long it takes babies to wean to 2L nasal cannula support or come off all support (room air, RA).
Study NCT05091905 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Infusion of ropivacaine 0.2%
Description: Patients will receive a continuous infusion of Ropivacaine 0.2% (6 mL/hr popliteal-sciatic and 8 mL/hr infraclavicular, 4 mL patient controlled bolus with 30-minute lockout) will be initiated in the recovery room.
Study NCT05091905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Titratable Automated Intermittent Boluses of ropivacaine 0.2%
Description: Patients will receive patient-titratable intermittent boluses of Ropivacaine 0.2% (8 mL popliteal-sciatic or 11 mL infraclavicular automated bolus every 120 minutes, 4 mL patient controlled bolus with 30-minute lockout). In addition, the infusion pump will be set in a pause mode that delays initiation of the automated bolus doses by 5 hours (this can be over-ridden by patients if they would like to initiate their perineural infusion earlier than 5 hours). Lastly, subjects will be able to titrate the volume of their automated bolus up or down within the range of 1-16 mL.
Study NCT05749744 — intervention group
Intervention type: OTHER
Intervention: cardiac telerehabilitation program by videoconference
Description: * A video conference interview with an Adapted Physical Activity (APA) teacher before starting physical training~* Exercise training for 3 weeks via distance coaching~* Therapeutic patient education (TPE) workshops conducted remotely with 1 workshop per week.~* Medical follow-up via teleconsultation~* Psychological and/or dietetic follow-up if necessary.~* Final assessment at 1 month with evaluation of aerobic metabolism, functional evaluation and final shared educational assessment (BEP).~* Appointment with an association Cœur et Santé and Sport-Santé 42 or setting up of an individual physical activity
Study NCT06349993 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Intervention
Description: game-based digital intervention app
Study NCT06349993 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Education
Description: traditional health education app
Study NCT05704465 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Reiki Therapy
Description: Reiki therapy involved 3 theoretical sessions, 4 practical sessions, and one final one for recapitulation and evaluation. In this technique, energy is guided by therapist's hands placed near patient's body to activate the ability of the body to heal and restore its balance. 1st session for explanation of aim and objectives of program. 2nd one focused on knowledge about negative emotional state. 3rd one discussed Reiki technique and its concept, mode of action, and process. The 4th through 7th sessions were practical. During these sessions, a Reiki practitioner moves his/her hands close to the patient's body in a set of positions. Each hand position focuses on a different part of the body. The hands are held in position for 3 to 10 min., depending on patient's needs. By the end of the session, the patient and therapist reflect on their experience and the emotions with the technique. The eighth session was a recapitulation of the program and ended with evaluation or post-testing.
Study NCT05704465 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Qi-gong Therapy
Description: Qi-gong involved 3 theoretical sessions, 4 practical sessions, and one final one for recapitulation and evaluation. It involves coordination of breathing and physical movement with mental energy to promote cognitive performance. Both 1st and 2nd sessions were similar to Reiki technique group. The 3rd one addressed the concept of Qi-gong therapy. The 4th through 7th sessions involved patients' doing simple movements and breathing techniques. The practitioner is at about a one-foot distance from the patient's body, to guide and manipulate movements. Breathing patterns are like yoga, with Qigong movements in a mindful link to inspiration and expiration, with incorporation of deep diaphragmatic breathing. The 8th session was similarly for program recapitulation and post-testing.
Study NCT06225050 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version)
Description: PBSC grafts from haploidentical donors depleted of TCRaβ+ cells and CD45RA+ cells using CliniMACS Prodigy® will be infused into patients intravenously (IV)
Study NCT05599516 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LIBP-Rec-Vaccine
Description: Intramuscular injection of LIBP-Rec-Vaccine in the deltoid muscle of the upper arm
Study NCT06158750 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: p64/p48 MW HPC Flow Modulation Device
Description: Endovascular intervention with p64/p48 MW HPC Flow Modulation Device was performed in patients diagnosed with intracranial aneurysms
Study NCT05885503 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RC-28E
Description: Ophthalmic solution for intravitreal injection administered as a 2.0mg/50 μL per dose.
Study NCT05885503 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept
Description: Ophthalmic solution for intravitreal injection administered as a 2.0mg/50 μL per dose.
Study NCT06362915 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: * Group (A) lidocaine : will receive blind local infiltration in femoral region on the operation side by an experienced anesthesiologist using 20 ml lidocaine 1%.
Study NCT06362915 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: • Group (B),bupivacaine: will receive ultrasound-guided ilioinguinal/iliohypogastric nerve block using 20 ml Bupivacaine 0.25% by an experienced anesthesiologist
Study NCT05103982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping with Infertility Program
Description: 6 10-minute videos with assigned homework
Study NCT05534581 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PVI using the Arctic Front Cryoballoon (Medtronic)
Description: Patients randomized to the Arctic Front cryoballoon group will undergo PVI using the Arctic Front Cryoballoon (Medtronic). At the end of the procedure, an implantable cardiac monitor will be implanted for the purpose of continuous arrhythmia monitoring.
Study NCT05534581 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: PVI using FARAPULSE Pulsed Field Ablation (Boston Scientific)
Description: Patients randomized to the Pulsed Field Ablation group will undergo PVI using the FARAPULSE PFA system (Boston Scientific). At the end of the procedure, an implantable cardiac monitor will be implanted for the purpose of continuous arrhythmia monitoring.
Study NCT05599516 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BIBP-Rec-Vaccine
Description: Intramuscular injection of BIBP-Rec-Vaccine in the deltoid muscle of the upper arm
Study NCT05184725 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SaMD CARINAE
Description: SaMD CARINAE delivers the following digital therapeutic intervention to the patients: 1) Personalised patient-centred health education program to improve patient's disease and recovery self-management skills. 2) AI-based behaviour change program to promote healthier lifestyle habits. 3) Personalised mental well-being coaching program to improve patient's ability to cope with emotional disturbances such as stress and anxiety. 4) A collaborative digital support platform to enable information exchange between patients, caregivers, and healthcare professionals.
Study NCT05777902 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod Oral Capsule
Description: We propose to integrate measurements obtained using multiple tools. Patients will undergo MRI and hdEEG procedures, and blood samples will be obtained for the immunological and biochemical studies on the same day. The study of the immune system's status will include an extensive immunophenotypic analysis, a functional characterization following ex vivo stimulation of innate immune cells, and the measurement of soluble products in the serum, such as cytokines. Cellular traits of interest include the absolute numbers and relative proportions of specific cell subsets, transcriptional states, secretory functions, proliferative capacity or cytolytic potential. Specifically, the following antibody combination will constitute the core of the immunophenotypic analysis: HLADR CD11c, CD38, CD14, CD123, lineage (CD3, CD56, CD19).
Study NCT05800132 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MammoScreen
Description: Diagnostic reading aid for breast cancer screening
Study NCT05600231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LISTERINE COOL MINT Antiseptic Mouthwash
Description: Participants will use LISTERINE COOL MINT Antiseptic Mouthwash for 30 second after brushing teeth twice daily.
Study NCT05600231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LISTERINE COOL MINT ZERO Alcohol Mouthwash
Description: Participants will use LISTERINE COOL MINT ZERO Alcohol Mouthwash for 30 second after brushing teeth twice daily.
Study NCT05600231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reach Unflavored Waxed Dental Floss
Description: Participants after brushing for 1 timed minute, will rinse mouth with water and Floss once a day.
Study NCT05600231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colgate Cavity Protection Toothpaste
Description: Participants will use Colgate Cavity Protection Toothpaste for brushing teeth twice daily.
Study NCT05599516 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Intramuscular injection of placebo in the deltoid muscle of the upper arm
Study NCT05017350 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: radiofrequency ablation
Description: Under the ultrasound guidance, the electrode is inserted into the bleeding focus of the liver and the bleeding focus is ablated.
Study NCT04661683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combustible Hookah Smoke
Description: Exposure to combustible hookah smoke for a duration of 60 minutes.
Study NCT04661683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Hookah Aerosol
Description: Exposure to electronic hookah aerosol for a duration of 60 minutes.
Study NCT04661683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clean Room Air
Description: Exposure to room air for a duration of 60 minutes.
Study NCT06134544 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Isomaltooligosaccharides (IMO)
Description: Patients will still receive standard treatment, including medicine and other invasive treatment.
Study NCT05164159 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol group
Description: During induction, the propofol group starts the effect site concentration at 4.0 ng/ml with TCI and adjusts it to around 3.0 \~ 4.0 ng/ml after intubation to maintain an appropriate EEG-based depth of anesthesia.
Study NCT05164159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: remimazolam group
Description: In the remimazolam group, start remimazolam at 6 mg/kg/hr and adjust it to 1 mg/kg/hr after loss of consciousness to maintain an appropriate EEG-based depth of anesthesia.